A modified spacer device for inhalational drug therapy for chronic bronchitis/asthma in laryngectomised patients

Following total laryngectomy, patients who need to continue their inhalatio nal drug therapy for chronic pulmonary conditions experience a great deal o f difficulty in administering the drugs. We describe a new spacer device to deliver inhalational drug therapy to laryngectomized patients which is sim ple to use and does not interfere with the patient's life style. The device involves a standard metered dose inhaler, a paediatric face mask and a sma ll volume spacer. This device was used successfully in six laryngectomised patients for 12-18 months, who needed to continue their inhalational drug t herapy for their pulmonary condition.